Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples